Bb Biotech as of March 31, 2014
Portfolio Holdings for Bb Biotech
Bb Biotech holds 24 positions in its portfolio as reported in the March 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 15.7 | $305M | 2.2M | 139.60 | |
| ISIS Pharmaceuticals | 14.0 | $272M | 6.3M | 43.21 | |
| Gilead Sciences (GILD) | 12.8 | $249M | 3.5M | 70.86 | |
| Incyte Corporation (INCY) | 11.4 | $221M | 4.1M | 53.52 | |
| Alexion Pharmaceuticals | 5.7 | $111M | 727k | 152.13 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 5.1 | $99M | 1.4M | 70.72 | |
| Medivation | 4.8 | $94M | 1.5M | 64.37 | |
| Synageva Biopharma | 4.0 | $78M | 940k | 82.97 | |
| Halozyme Therapeutics (HALO) | 3.7 | $72M | 5.6M | 12.70 | |
| Regeneron Pharmaceuticals (REGN) | 3.5 | $67M | 223k | 300.28 | |
| Pharmacyclics | 3.3 | $64M | 637k | 100.22 | |
| Endocyte | 3.0 | $59M | 2.5M | 23.81 | |
| Neurocrine Biosciences (NBIX) | 2.5 | $48M | 3.0M | 16.10 | |
| ImmunoGen | 2.4 | $47M | 3.2M | 14.93 | |
| Clovis Oncology | 1.7 | $34M | 488k | 69.27 | |
| Alnylam Pharmaceuticals (ALNY) | 1.6 | $32M | 471k | 67.14 | |
| Theravance | 1.4 | $28M | 888k | 30.94 | |
| Tesaro | 0.9 | $18M | 605k | 29.48 | |
| Infinity Pharmaceuticals (INFIQ) | 0.8 | $16M | 1.3M | 11.89 | |
| Puma Biotechnology (PBYI) | 0.6 | $12M | 118k | 104.14 | |
| Idenix Pharmaceuticals | 0.4 | $7.5M | 1.3M | 6.03 | |
| Achillion Pharmaceuticals | 0.3 | $5.9M | 1.8M | 3.29 | |
| Ariad Pharmaceuticals | 0.1 | $1.4M | 172k | 8.06 | |
| Cubist Pharmaceutic-cvr | 0.0 | $570k | 876k | 0.65 |
